Therapeutic Asset Ratings
395 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Vio-01
Prostate Cancer
Valerio Therapeutics
P1/2
CC
(40)
xnw5004
Prostate Cancer
Evopoint Biosciences Inc.
P1/2
CC
(40)
[68ga]ga-oncoacp3
Prostate Cancer
Philogen S.p.A.
P1
C
(39)
[99mTc]Tc-BQ0413
Prostate Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences
P1
C
(39)
[99mtc]tc-db8
Prostate Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences
P1
C
(39)
Agn-Cogni.Q
Prostate Cancer
Milton S. Hershey Medical Center
P1
C
(39)
RIFALDAZINE
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
P1
C
(39)
Sol-804-F
Prostate Cancer
Bukwang Pharmaceutical
P1
C
(39)
pf-05212384
Prostate Cancer
Celcuity Inc
P1/2
C
(39)
[177Lu]Lu-A9-0631
Prostate Cancer
Alpha-9 Oncology USA Inc.
P1
C
(36)
[225Ac]Ac-A9-0642
Prostate Cancer
Alpha-9 Oncology USA Inc.
P1
C
(36)
[225Ac]Ac-AKY-2519
Prostate Cancer
Aktis Oncology, Inc.
P1
C
(36)
225ac-psma-r2
Prostate Cancer
Novartis Pharmaceuticals
P1
C
(36)
[64Cu]Cu-AKY-2519
Prostate Cancer
Aktis Oncology, Inc.
P1
C
(36)
89zr-dfo-psmai-peg-cy5.5-c' dots
Prostate Cancer
Memorial Sloan Kettering Cancer Center
P1
C
(36)
[Ac-225]-Psma-62
Prostate Cancer
Eli Lilly and Company
P1
C
(36)
ACTINIUM (225AC) PSMA-617
Prostate Cancer
Thomas Hope
P1
C
(36)
agx101
Prostate Cancer
Angiex, Inc.
P1
C
(36)
Amg 509
Prostate Cancer
Amgen
P1
C
(36)
Balstilimab
Prostate Cancer
Agenus Inc.
P1
C
(36)
bg-68501
Prostate Cancer
BeiGene
P1
C
(36)
Bgb-43395
Prostate Cancer
BeiGene
P1
C
(36)
BLOOD, WHOLE
Prostate Cancer
Mayo Clinic
P1
C
(36)
Botensilimab
Prostate Cancer
Agenus Inc.
P1
C
(36)
Bp-C2
Prostate Cancer
Meddoc
P1
C
(36)
Showing 276 to 300 of 395 assets
Previous
Page 12 of 16
Next